These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 35418024)

  • 41. Differences in the extent of fibrosis in obstructive and nonobstructive hypertrophic cardiomyopathy.
    Avegliano G; Politi MT; Costabel JP; Kuschnir P; Trivi M; Ronderos R
    J Cardiovasc Med (Hagerstown); 2019 Jun; 20(6):389-396. PubMed ID: 30994509
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relationship between left ventricular mass, wall thickness, and survival after subaortic septal myectomy for hypertrophic obstructive cardiomyopathy.
    Brown ML; Schaff HV; Dearani JA; Li Z; Nishimura RA; Ommen SR
    J Thorac Cardiovasc Surg; 2011 Feb; 141(2):439-43. PubMed ID: 20832083
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Subaortic and midventricular obstructive hypertrophic cardiomyopathy with extreme segmental hypertrophy.
    Efthimiadis GK; Giannakoulas G; Parcharidou DG; Ziakas AG; Papadopoulos CE; Karoulas T; Pliakos C; Parcharidis G
    Cardiovasc Ultrasound; 2007 Mar; 5():12. PubMed ID: 17349063
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PET/CT assessment of symptomatic individuals with obstructive and nonobstructive hypertrophic cardiomyopathy.
    Bravo PE; Pinheiro A; Higuchi T; Rischpler C; Merrill J; Santaularia-Tomas M; Abraham MR; Wahl RL; Abraham TP; Bengel FM
    J Nucl Med; 2012 Mar; 53(3):407-14. PubMed ID: 22315440
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combined transaortic and transapical approach to septal myectomy in patients with complex hypertrophic cardiomyopathy.
    Hang D; Schaff HV; Ommen SR; Dearani JA; Nishimura RA
    J Thorac Cardiovasc Surg; 2018 May; 155(5):2096-2102. PubMed ID: 29153286
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Altered autonomic cardiac control in hypertrophic cardiomyopathy. Role of outflow tract obstruction and myocardial hypertrophy.
    Limbruno U; Strata G; Zucchi R; Baglini R; Mengozzi G; Balbarini A; Mariani M
    Eur Heart J; 1998 Jan; 19(1):146-53. PubMed ID: 9503188
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnostic performance of ultrasonic tissue characterization for subendocardial ischaemia in patients with hypertrophic cardiomyopathy.
    Kawasaki T; Yamano M; Sakai C; Harimoto K; Miki S; Kamitani T; Sugihara H
    Eur Heart J Cardiovasc Imaging; 2013 Aug; 14(8):790-6. PubMed ID: 23221313
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A 66-Year-Old Female with Apical Hypertrophic Cardiomyopathy Presenting with Hypertensive Crises and Type 2 Myocardial Infarction and a Normal Coronary Angiogram.
    Meghrajani V; Wats K; Saxena A; Malik B
    Case Rep Cardiol; 2018; 2018():7089149. PubMed ID: 30498604
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Myocardial work is associated with significant left ventricular myocardial fibrosis in patients with hypertrophic cardiomyopathy.
    Gonçalves AV; Rosa SA; Branco L; Galrinho A; Fiarresga A; Lopes LR; Thomas B; Baquero L; Carmo MM; Ferreira RC
    Int J Cardiovasc Imaging; 2021 Jul; 37(7):2237-2244. PubMed ID: 33598850
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intraoperative Diagnosis of Anderson-Fabry Disease in Patients With Obstructive Hypertrophic Cardiomyopathy Undergoing Surgical Myectomy.
    Cecchi F; Iascone M; Maurizi N; Pezzoli L; Binaco I; Biagini E; Fibbi ML; Olivotto I; Pieruzzi F; Fruntelata A; Dorobantu L; Rapezzi C; Ferrazzi P
    JAMA Cardiol; 2017 Oct; 2(10):1147-1151. PubMed ID: 28793143
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Regression of giant negative T waves in hypertrophic cardiomyopathy: cases simulating either dilated cardiomyopathy or severe coronary artery stenosis].
    Horita Y; Konishi K; Osato K; Nakao T; Namura M; Kanaya H; Ohka T; Genda A; Takeda R
    J Cardiol; 1988 Sep; 18(3):875-85. PubMed ID: 3249296
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Paradoxical response to exercise in asymptomatic hypertrophic cardiomyopathy: a new description of outflow tract obstruction dynamics.
    Lafitte S; Reant P; Touche C; Pillois X; Dijos M; Arsac F; Peyrou J; Montaudon M; Ritter P; Roudaut R; Demaria A
    J Am Coll Cardiol; 2013 Aug; 62(9):842-50. PubMed ID: 23810875
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systolic and diastolic myocardial mechanics in hypertrophic cardiomyopathy and their link to the extent of hypertrophy, replacement fibrosis and interstitial fibrosis.
    Nucifora G; Muser D; Gianfagna P; Morocutti G; Proclemer A
    Int J Cardiovasc Imaging; 2015 Dec; 31(8):1603-10. PubMed ID: 26210792
    [TBL] [Abstract][Full Text] [Related]  

  • 54. T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
    Ho CY; Abbasi SA; Neilan TG; Shah RV; Chen Y; Heydari B; Cirino AL; Lakdawala NK; Orav EJ; González A; López B; Díez J; Jerosch-Herold M; Kwong RY
    Circ Cardiovasc Imaging; 2013 May; 6(3):415-22. PubMed ID: 23549607
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Therapeutic management of hypertrophic obstructive cardiomyopathy: alcohol septal ablation or surgical myomectomy?
    Noble S; Sigwart U
    Expert Rev Cardiovasc Ther; 2014 Sep; 12(9):1041-4. PubMed ID: 25039895
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treating a Structural Heart Disease Using a Non-structural Approach: Role of Cardiac Pacing in Hypertrophic Cardiomyopathy.
    Albano BB; Fadreguilan EC; Chua JM; Ho J; Medrano AB
    Cardiol Res; 2017 Feb; 8(1):20-25. PubMed ID: 28275421
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterisation of patients with and without cardiac magnetic resonance imaging abnormalities presenting with myocardial infarction with non-obstructive coronary arteries (MINOCA).
    Tayal B; Freeman P; Ericsson F; Kragholm KH; Andersen NH; Hagendorff A; Aaroe J; Sogaard P; Zaremba T
    Acta Cardiol; 2021 Sep; 76(7):760-768. PubMed ID: 32594904
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Extended septal myectomy and left ventricular outflow tract intervention for hypertrophic obstructive cardiomyopathy.
    Pruna-Guillen R; Ascaso M; Affronti A; Quintana E
    Multimed Man Cardiothorac Surg; 2021 Mar; 2021():. PubMed ID: 33691043
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hypertrophic cardiomyopathy with apical left ventricular aneurysm.
    Akutsu Y; Shinozuka A; Huang TY; Watanabe T; Yamada T; Yamanaka H; Saitou T; Geshi E; Takenaka H; Takeyama Y; Munechika H; Ban Y; Katagiri T
    Jpn Circ J; 1998 Feb; 62(2):127-31. PubMed ID: 9559432
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Patients Without Severe Septal Hypertrophy: Implications of Mitral Valve and Papillary Muscle Abnormalities Assessed Using Cardiac Magnetic Resonance and Echocardiography.
    Patel P; Dhillon A; Popovic ZB; Smedira NG; Rizzo J; Thamilarasan M; Agler D; Lytle BW; Lever HM; Desai MY
    Circ Cardiovasc Imaging; 2015 Jul; 8(7):e003132. PubMed ID: 26082555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.